Home		Research and Development

Global Interface -Transforming Research & Development

Medical research has come a long way in the last hundred years, yet there are still many diseases for which there are no effective treatments.

That's why GlaxoSmithKline is committed to discovering and developing new medicines and vaccines. Being a large company, we can truly make a difference because we can devote vast resources to discover and develop new medicines and vaccines.

GSK has more than 20 research and development (R&D) facilities around the world, with an annual R&D budget of around $7 billion and more than 16,000 people employed in R&D.

R&D Themes under the GSK strategy:

Best Science: Focusing our efforts in areas where the science is most fertile to discover new medicines of value to both patients and payers

Re-personalise R&D: Creating small teams, where an individual can have a personal impact and be intimate with the project

Diversify through Externalisation: We will scout the world to find new science and ideas

Focus on Return on Investment: We will spend less on buildings and infrastructure and more on our growing late stage pipeline



The Research Process: